PT93933A - Metodos e materiais para a expressao de plasminogenio humano em um sistema de celula eucariotica a que falta um activador de plasminogenio de sitio especifico - Google Patents
Metodos e materiais para a expressao de plasminogenio humano em um sistema de celula eucariotica a que falta um activador de plasminogenio de sitio especifico Download PDFInfo
- Publication number
- PT93933A PT93933A PT93933A PT9393390A PT93933A PT 93933 A PT93933 A PT 93933A PT 93933 A PT93933 A PT 93933A PT 9393390 A PT9393390 A PT 9393390A PT 93933 A PT93933 A PT 93933A
- Authority
- PT
- Portugal
- Prior art keywords
- plasminogen
- cdc cdc
- mmm
- quot
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34580189A | 1989-05-01 | 1989-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT93933A true PT93933A (pt) | 1991-01-08 |
Family
ID=23356538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT93933A PT93933A (pt) | 1989-05-01 | 1990-04-30 | Metodos e materiais para a expressao de plasminogenio humano em um sistema de celula eucariotica a que falta um activador de plasminogenio de sitio especifico |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0467987A4 (ja) |
JP (1) | JPH05500748A (ja) |
AU (1) | AU647391B2 (ja) |
FI (1) | FI915149A0 (ja) |
PT (1) | PT93933A (ja) |
WO (1) | WO1990013640A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
US6743623B2 (en) | 1991-09-27 | 2004-06-01 | Centre National De La Recherche Scientifique | Viral recombinant vectors for expression in muscle cells |
FR2681786A1 (fr) * | 1991-09-27 | 1993-04-02 | Centre Nat Rech Scient | Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires. |
US6099831A (en) * | 1992-09-25 | 2000-08-08 | Centre National De La Recherche Scientifique | Viral recombinant vectors for expression in muscle cells |
US5945403A (en) | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
EP1337548B1 (en) | 2000-11-28 | 2008-07-16 | David M. Waisman | Anti-angiogenic polypeptides |
WO2002050290A1 (en) * | 2000-12-21 | 2002-06-27 | Thromb-X Nv | A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
US7067492B2 (en) * | 2001-09-06 | 2006-06-27 | Omnio Ab | Method of promoting healing of a tympanic membrane perforation |
CA2514873C (en) | 2002-12-13 | 2012-01-03 | David Waisman | Compositions and methods for inhibiting tumor growth and metastasis |
US20120220015A1 (en) * | 2009-05-26 | 2012-08-30 | Biolex Therapeutics | Compositions and methods for production of aglycosylated plasminogen |
JP5819293B2 (ja) | 2009-07-10 | 2015-11-24 | スロンボジェニックス・ナムローゼ・フェンノートシャップThromboGenics NV | プラスミノーゲンおよびプラスミンの変異体 |
WO2012093132A1 (en) | 2011-01-05 | 2012-07-12 | Thrombogenics Nv | Plasminogen and plasmin variants |
AU2012296884B2 (en) | 2011-08-12 | 2015-02-05 | Thrombogenics N.V. | Plasminogen and plasmin variants |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3943245A (en) * | 1974-02-14 | 1976-03-09 | Armour Pharmaceutical Company | Purification of plasminogen |
DE3065190D1 (en) * | 1979-11-05 | 1983-11-10 | Beecham Group Plc | Enzyme derivatives, and their preparation |
US4769331A (en) * | 1981-09-16 | 1988-09-06 | University Patents, Inc. | Recombinant methods and materials |
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
-
1990
- 1990-04-26 EP EP19900907737 patent/EP0467987A4/en not_active Withdrawn
- 1990-04-26 JP JP2507792A patent/JPH05500748A/ja active Pending
- 1990-04-26 AU AU56596/90A patent/AU647391B2/en not_active Expired - Fee Related
- 1990-04-26 WO PCT/US1990/002296 patent/WO1990013640A1/en not_active Application Discontinuation
- 1990-04-30 PT PT93933A patent/PT93933A/pt not_active Application Discontinuation
-
1991
- 1991-10-31 FI FI915149A patent/FI915149A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0467987A1 (en) | 1992-01-29 |
EP0467987A4 (en) | 1992-07-08 |
WO1990013640A1 (en) | 1990-11-15 |
FI915149A0 (fi) | 1991-10-31 |
AU647391B2 (en) | 1994-03-24 |
JPH05500748A (ja) | 1993-02-18 |
AU5659690A (en) | 1990-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4426650B2 (ja) | 新規な抗血管形成ペプチド、それをコードするポリヌクレオチド、および血管形成を阻害する方法 | |
JP4722989B2 (ja) | 新規な抗血管形成ペプチド、それをコードするポリヌクレオチド、および血管形成を阻害する方法 | |
US6201104B1 (en) | Angiogenesis—inhibiting protein binding peptides and proteins and methods of use | |
JP4411330B2 (ja) | 腫瘍壊死因子関連リガンド | |
CN1145636A (zh) | 血管内皮生长因子2 | |
JPH02442A (ja) | エリトロポエチンを発現するヒトcDNAのクローニング方法 | |
JPH11503901A (ja) | インターロイキン−1β転換酵素様アポトーシスプロテアーゼ−3および4 | |
PT93933A (pt) | Metodos e materiais para a expressao de plasminogenio humano em um sistema de celula eucariotica a que falta um activador de plasminogenio de sitio especifico | |
JPH10508742A (ja) | ヒトケモカインポリペプチド | |
US7282351B2 (en) | Prostatic growth factor | |
JP3670665B2 (ja) | 単球走化性蛋白質−4 | |
WO1996018730A1 (en) | Prostatic growth factor | |
JPH10500301A (ja) | マクロファージ遊走阻止因子−3 | |
JPH10513355A (ja) | ヒトケモカインβ−11およびヒトケモカインα−1 | |
US5087572A (en) | Dna encoding human plasminogen modified at the cleavage site | |
JP2003047483A (ja) | インターロイキン−6スプライス変異体 | |
JPH10504441A (ja) | Tnf形成阻害のための組成物およびその使用 | |
US5190756A (en) | Methods and materials for expression of human plasminogen variant | |
JP2002085082A (ja) | スーパーオキシドジスムターゼ−4 | |
JPH11501802A (ja) | ユビキチン結合酵素7、8および9 | |
JPH11507809A (ja) | ヒト肝ガン由来増殖因子−2 | |
US7416855B2 (en) | Immunoassay methods for detecting interleukin-1 β converting enzyme like apoptosis protease-3 | |
KR100506571B1 (ko) | 플라스미노겐으로부터유래된맥관형성억제펩타이드 | |
JP2000506371A (ja) | 成長因子htter36 | |
JP2006087443A (ja) | トランスフォーミング増殖因子αHII |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC3A | Refusal |
Effective date: 19960226 |